Exporting Supplements from India: Compliance, Markets & How to Get Started

India is a fast-growing supplement manufacturing base, and more Indian founders are being asked the same question by a distributor in Dubai, a clinic in Singapore, or a buyer on Amazon.com: can you ship to us? The answer is usually yes. The work is in the paperwork.

To export supplements from India you clear two gates at home, then meet the rules of wherever the goods are going. The home gates are an IEC and an FSSAI licence. The destination rules change by country: the Gulf wants product registration and Arabic labels, the USA wants FDA facility registration and correct claim language, Southeast Asia and the neighbours want a local importer and, in most markets, a product dossier. None of it is exotic. Most of it is a checklist you run once and reuse.

This guide walks the path in the order you actually hit it. It is practical, not legalistic. Treat it as a map, and confirm the current fine print with the relevant authority or a customs broker before you commit a shipment.

Start with the Importer Exporter Code (IEC). It is issued by the DGFT, linked to your PAN, applied for online, and carries a ₹500 government fee. Without it, customs will not clear a commercial export. It is effectively one-time, but since 2021 you must confirm or update the IEC online once a year between April and June (no fee for the update) or it is deactivated. Get this first — everything else assumes you have it.

Second is your FSSAI licence. Health supplements and nutraceuticals are governed by FSSAI's nutraceutical framework — originally the FSS (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, which FSSAI has been replacing with its 2022 'Nutra' regulations, operationalised through directions. Exporters typically apply for a Central Licence on FoSCoS (100% export-oriented units must); check the kind-of-business category for your setup before you file. The same licence that lets you sell in India is the one an importing country's authority will want to see as evidence the product is legally made and sold at origin.

A third, optional step: a Registration-cum-Membership Certificate (RCMC) from the relevant export promotion council — SHEFEXIL is the designated council for nutraceuticals, while herbal or Ayush lines may sit with APEDA or AYUSHEXCIL. You need it to claim export-promotion benefits or if a buyer asks for it, but it is not a hard gate. You do not need it to make your first shipment move.

Every export carries a document set. Some are generic trade papers — commercial invoice, packing list, bill of lading or airway bill. The ones specific to supplements are where deals stall if you are not ready.

The Certificate of Analysis (COA) is the core. It is a lot-specific test report — identity, potency, and purity (heavy metals, microbial limits) — for the exact batch in the box, from an accredited lab. A serious importer will not take a nutraceutical without one, and in several markets port authorities can sample and test shipments against it. A Free Sale and Commerce Certificate tells the destination authority the product is legally sold in India; for food and supplement lines outside the Drugs and Cosmetics Act it is applied for online through the DGFT, and many Gulf and Asian registrations ask for it. Depending on the country you may also need a health or export certificate, a Certificate of Origin (which, under India's trade agreements, can cut the duty the importer pays), and for most of the Gulf, Halal certification — especially where the product uses animal-derived inputs such as gelatin capsules.

Build these as a reusable pack. The COA regenerates per batch; the free-sale, origin, and Halal documents are largely standing documents you refresh before they expire. The founders who struggle are the ones assembling this for the first time under a buyer's deadline.

The GCC is often an Indian brand's first export market — close, large, and, in the UAE's case, connected to India by the India-UAE CEPA, in force since May 2022, which lowers tariffs on many goods. It is also registration-heavy. You do not just ship; the product is registered before it sells.

In the UAE, the route depends on how the product is classified. Supplements with health claims or medicinal-strength doses have been registered with the federal regulator — MOHAP, whose product-registration services have been moving to the new Emirates Drug Establishment (EDE) — while products classified as food go through municipal systems such as Dubai Municipality's. Labels must carry Arabic alongside English, and Halal certification is expected wherever animal-derived ingredients are involved. In Saudi Arabia, the SFDA (Saudi Food and Drug Authority) registers supplements before they can be sold — through its food sector, or as health or herbal products in its drug sector where claims or doses push them there — again with Arabic labelling. SFDA-regulated products clear through the SFDA, not SASO's SABER platform.

The practical lesson: a Gulf label is not your Indian label with a sticker. It is a separate artwork variant — Arabic panel, local registration number, importer details — produced before the batch runs. Plan label work as part of the formulation timeline, not an afterthought at dispatch.

The USA does not pre-approve supplements. Under DSHEA, dietary supplements reach market without the FDA clearing them first — which is not the same as no rules. The rules are real; they just sit with the facility, the importer, and the label.

Four things matter. The manufacturing facility registers with the FDA as a food facility, names a US agent, and renews every two years. Each shipment needs Prior Notice filed before it arrives. The US importer runs a Foreign Supplier Verification Program (FSVP) — they are legally accountable for verifying your supplier, so expect them to ask for your cGMP (21 CFR 111) and COA documentation. And the label follows US format: a Supplement Facts panel and, wherever the label makes a structure/function claim, the DSHEA disclaimer — "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." The company making that claim also notifies the FDA within 30 days of first marketing it.

Claims are the trap. US supplement claims must be structure/function language — an ingredient supports or helps maintain a normal function. The moment copy drifts toward treating or curing a condition, the product reads as an unapproved drug. Write labels and listings as supports, not cures, from the first draft.

The rest of Asia is reachable but document-heavy, and lead times can run longer than the Gulf. Most countries want a local importer and, usually, a product registration or classification backed by a dossier — your formula, specs, COA, and free-sale certificate.

Singapore is the lighter touch: the HSA (Health Sciences Authority) does not pre-approve health supplements or license their dealers, but the importer is responsible for meeting HSA's rules on prohibited ingredients, heavy-metal limits, and labelling and claims. Sri Lanka, connected to India by the ISFTA trade agreement, treats supplements as borderline products — the NMRA classifies and registers them, and the Food Control Administration Unit checks imports at the border. Nepal splits oversight between the Department of Food Technology and Quality Control and the DDA (Department of Drug Administration) depending on classification, and Myanmar works through its FDA — both reward a complete dossier and patience.

The common thread: an in-market importer or distributor does much of the registration legwork, but only if you hand them a clean, complete document pack. A missing COA or an out-of-date free-sale certificate can add weeks.

Here is the quiet advantage. Most of the friction above is first-time friction — the first Arabic label, the first FSVP questionnaire, the first registration dossier. A contract manufacturer that already serves a market has absorbed that cost once and reuses it.

That shows up in concrete ways. A COA already formatted the way an SFDA or FSVP reviewer expects it. Free-sale and origin documents already on file. Label variants already built per market. Branded, patented actives — KSM-66 ashwagandha, Curcumin C3, HIMABERB berberine, Ferrochel, K2VITAL, HOWARU, LGG and BB-12 probiotics — that arrive with licensor documentation a foreign reviewer recognises, rather than a generic extract you have to defend from scratch. Batch testing that holds the same standard across every destination, so one border's lab result does not contradict another's.

You are not just buying capsules. You are buying someone else's export mileage — the dossiers, the label discipline, and the testing paper trail that turn a new market from a months-long project into a repeat process.

Insignis Bioscience is a private-label and custom supplement manufacturer (CDMO) in India, built asset-light across an audited WHO-GMP partner network. We serve 8 markets — India, the UAE, Saudi Arabia, the USA, Sri Lanka, Singapore, Nepal, and Myanmar — so the export questions above are ones we work through routinely, not something you face alone under a buyer's deadline.

The working mechanics are simple. 8 dosage formats and 44+ ready-to-brand formulas to start from, or a custom formulation built around branded actives such as KSM-66, Curcumin C3, HIMABERB, Ferrochel, K2VITAL, and HOWARU/LGG/BB-12 probiotics. Every batch is tested, and a COA ships with every lot — the single document most export registrations hinge on. Low MOQs, so a new brand can test a market without a container-load commitment.

If you are mapping an export plan — or just want to know which of your target markets is the shortest path to a first shipment — tell us the markets, the format, and the actives you have in mind. You will have a costed quote within two business days.